The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version)
Shi, Y.
Zhonghua Zhong Liu Za Zhi 37(10): 796-799
2015
ISSN/ISBN: 0253-3766 PMID: 26813604 Document Number: 681257
Document emailed within 1 workday
Related Documents
Li, Z.; Zhang, L-jun.; Wang, W-ping.; Guo, K.; Shao, J-yong.; Rong, T-hua. 2011: Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 33(9): 666-670Zhang, J.Q.; Xu, F.; Xu, X.L.; Zhou, H.C. 2017: Erlotinib in the treatment of small cell lung cancer with EGFR mutation: a case report Zhonghua Zhong Liu Za Zhi 39(9): 717-719
Shepherd, F.A. 2016: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patients Clinical Advances in Hematology and Oncology: H&o 14(1): 41-43
Li, J.; Hong, Q.; Zhang, X.; Hu, J.; Bai, C. 2014: Therapeutic efficacy and safety of chemotherapy subsequent EGFR-TKi in advanced non-small cell lung cancer patients with EGFR-TKi acquired resistance Zhonghua Yi Xue Za Zhi 94(30): 2342-2345
Urata, Y.; Satouchi, M. 2015: I. what is the Standard Treatment of EGFR-TKIs? Did EGFR-TKIs Improve Treatment for Non-Small Cell Lung Cancer? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 931-934
Yang, B.; Zheng, D.; Zeng, Υa.; Qin, A.; Gao, J.; Yu, G. 2018: Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(4): 1077-1081
Jin, B.; Zhang, Y.; Zhang, X.; Li, R.; Lou, Y.; Niu, Y.; Huang, A.; Han, B. 2014: Value of carcinoembryonic antigen levels in predicting the efficacy of EGFR-TKi in advanced non-small cell lung cancer harboring EGFR mutations Zhonghua Yi Xue Za Zhi 94(30): 2327-2331
Gombos, Z.; Danihel, L.; Puttaswamy, K.; Brose, M. 2010: A comparative study of EGFR mutation screening methods in non-small cell carcinoma of lung Bratislavske Lekarske Listy 111(7): 365-368
Dahse, R.; Berndt, A.; Kosmehl, H. 2008: PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer Anticancer Research 28(4b): 2265-2270
Saxena, A.; Nagasaka, M.; Li, Z.; Becker, D.J.; Levy, B.P. 2014: Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer Oncology 28(6): 526; 528 530, 534
Thongprasert, S.; Intarapak, S.; Saengsawang, P.; Thaikla, K. 2005: Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients Journal of the Medical Association of Thailand 88(12): 1809-1815
Xu, C.-a.; Su, H.; Liu, J.-l.; Li, L.; Zou, H.-w. 2011: Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor Zhonghua Zhong Liu Za Zhi 33(6): 436-441
Dong, Q.-g.; Han, B.-h.; Huang, J.-s.; Yang, L.-m.; Huang, J.; Zhao, C.-y.; Lu, L.-q. 2006: Analysis of EGFR mutations in 176 cases of non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 28(9): 686-690
Forde, P.M.; Ettinger, D.S. 2015: Managing acquired resistance in EGFR-mutated non-small cell lung cancer Clinical Advances in Hematology and Oncology: H&o 13(8): 528-532
Karnaoukhova, L.; Moffat, J.; Martins, H.; Glickman, B. 1997: Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy Cancer Research 57(19): 4393-4407
Petmitr, S.; Makthiengtrong, S.; Sutinont, P.; Migasena, P. 1999: p53 gene mutations in non-small cell lung cancer from Thai patients Journal of the Medical Association of Thailand 82(3): 250-255
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Zhang, L.; Wang, S.-L.; Zhang, X.-T.; Li, L.-Y.; Wang, M.-Z. 2007: Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer Zhonghua Nei Ke Za Zhi 46(5): 392-395
Morodomi, Y.; Okamoto, T.; Kohno, M.; Katsura, M.; Takada, K.; Suzuki, Y.; Fujishita, T.; Kitahara, H.; Shimamatsu, S.; Yoshida, T.; Tagawa, T.; Okano, S.; Maehara, Y. 2015: Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer Anticancer Research 35(3): 1791-1796
Koroleva, E.S.; Losenkov, I.S.; Alifirova, V.M.; Ivanova, S.A.; Goldberg, V.E.; Novikova, N.S. 2014: Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 93-96